市場調査レポート
商品コード
1410820
BCR-ABL検査市場:セグメント別規模、シェア、法規制、償還、2033年までの予測BCR-ABL Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
BCR-ABL検査市場:セグメント別規模、シェア、法規制、償還、2033年までの予測 |
出版日: 2023年12月14日
発行: GlobalData
ページ情報: 英文
納期: 即納可能
|
白血病は、血液と骨髄に影響を及ぼす異種のがん群です。2つの一般的な亜型はリンパ性白血病と骨髄性白血病で、それぞれリンパ球と骨髄球に由来します。白血病は急速に進行するもの(急性)と緩徐に進行するもの(慢性)があり、20歳未満の小児および若年成人のがんによる死亡の主な原因となっています。白血病には標準的な病期分類はなく、未治療、寛解期、再発のいずれかに分類されます。
BCR-ABLはフィラデルフィア(Ph)染色体としても知られる突然変異であり、22番染色体上のBCR遺伝子と9番染色体上のABL1遺伝子の染色体相互転座によって形成されます。この転座の結果、BCR-ABL融合遺伝子が生じ、チロシンキナーゼシグナル伝達タンパク質である融合タンパク質が産生され、このタンパク質は構成的に活性化されるため、細胞分裂が制御不能になります。
BCR-ABL検査には、BCR-ABLin situ ハイブリダイゼーション(ISH)、BCR-ABL核酸増幅(NAATs)、BCR-ABL次世代シーケンシング(NGS)、BCR-ABLサンガーシーケンシング、BCR-ABLパイロシーケンシングおよび細胞遺伝学検査が含まれます。
当レポートは、世界のBCR-ABL検査市場について詳細に考察し、市場における競合情勢、SWOT分析、2033年までの市場予測、COVID-19の影響、地域、国別の動向などを提供しています。
Not Applicable
Not Applicable
BCR-ABL Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area.
The model discusses in detail the impact of COVID-19 on BCR-ABL Tests market for the year 2020 and beyond. Leukemia is a heterogeneous group of cancers that affects the blood and bone marrow. Two common subtypes are lymphocytic leukemia's and myeloid leukemia's, which derive from lymphoid cells and myeloid cells, respectively. Leukemia can progress rapidly (acute), or slowly (chronic), and is the primary cause of deaths from cancer in children and young adults under the age of 20 years. There is no standard staging system for leukemia; the disease as described as untreated, in remission, or recurrent.
BCR-ABL is a mutation, also known as the Philadelphia (Ph) chromosome, which is formed by a reciprocal chromosomal translocation of the BCR gene on chromosome 22 with the ABL1 gene on chromosome 9. This translocation results in a BCR-ABL fusion gene and production of a fusion protein - a tyrosine kinase signaling protein this is constitutively active, causing cells to divide uncontrollably.
The BCR-ABL tests include BCR-ABL In Situ Hybridization (ISH), BCR-ABL Nucleic Acid Amplification (NAATs), BCR-ABL Next Generation Sequencing (NGS), BCR-ABL Sanger Sequencing, BCR-ABL Pyrosequencing and Cytogenetics tests.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed BCR-ABL tests and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Abbott Laboratories, Sysmex Corp, Bio-Techne Corp, Danaher Corp, Bio-Rad Laboratories Inc, Qiagen NV, Agilent Technologies Inc, Illumina Inc, Thermo Fisher Scientific Inc, Takara Bio Inc, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to-
Not Applicable